Intellectual Property


Daniel Palmer is Counsel in the Firm's Intellectual Property Practice Group. His practice is focused on patent prosecution, including the preparation of national and international patent applications and reports on patentability, infringement, and validity.

Prior to attending law school, Daniel worked at the Research Institute for Children at Children’s Hospital, New Orleans, performing research into roles of G-protein mediated signal transduction in fungal pathogenesis.

Prior to joining Brown Rudnick, Daniel was an associate at a national trial law firm, working on litigation in the areas of personal injury, contracts, patent infringement, civil rights, employment law, and products liability.


Northwestern University School of Law – J.D., 2009
Tulane University – B.S.E., 2003

Bar Admissions

Rhode Island
US District Court for the District of Massachusetts
US District Court for the District of Rhode Island
US Patent and Trademark Office
US Supreme Court
Co-author, “Gib2, a novel Gbeta-like/RACK1 homolog function as a Gbeta subunit in cAMP signaling and is essential in Cryptococcus neoformans,” J. Biol. Chem; 281: 32596-605 (2006)
Co-author, “Mutation of the regulator of G protein signaling Crg1 increases virulence in Cryptococcus neoformans,” Eukaryot Cell; v.3(4): 1028-35 (August 2004)